InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (29 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
29
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Young Jonathan, Chief Operating Officer. Insider active across 1 company, notably Akero Therapeutics, Inc.. Cumulatively, 55 disclosures have been recorded. Split: 0 buy · 29 sells. Total volume traded: €5.1m. Activity tracked since 3 May 2021. The latest transaction was disclosed on 24 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Young Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations55 total
152,616 sharesCommon StockSEC:0001193125-25-312092:0
20,000 sharesCommon StockSEC:0001193125-25-312092:1
20,000 sharesCommon StockSEC:0001193125-25-312092:2
20,000 sharesCommon StockSEC:0001193125-25-312092:3
47,573 sharesCommon StockSEC:0001193125-25-312092:4
4,284 shares@ US$21.091.0% of flowCommon StockSEC:0001193125-25-300488:0
12,500 shares@ US$21.102.8% of flowCommon StockSEC:0001193125-25-230294:0
586 shares@ US$43.020.3% of flowCommon StockSEC:0000950170-25-114666:0
12,500 shares@ US$21.103.0% of flowCommon StockSEC:0001779805-25-000007:0
12,500 shares@ US$21.103.0% of flowCommon StockSEC:0000950170-25-108234:0
890 shares@ US$23.8680.2% of flowCommon StockSEC:0000950170-25-093321:0
1,453 shares@ US$54.841.0% of flowCommon StockSEC:0000950170-25-088635:0
2,493 shares@ US$53.9931.7% of flowCommon StockSEC:0000950170-25-085667:0
607 shares@ US$44.880.3% of flowCommon StockSEC:0000950170-25-039745:0
11,447 shares@ US$44.1686.2% of flowCommon StockSEC:0000950170-25-033998:0
5,100 shares@ US$53.5653.4% of flowCommon StockSEC:0000950170-25-014188:0
43,064 shares@ US$6.3643.4% of flowCommon StockSEC:0000950170-25-009326:0
10,000 shares@ US$28.0333.5% of flowCommon StockSEC:0000950170-25-001850:0
24,300 shares0Common StockSEC:0000950170-24-138152:0
2,503 shares@ US$30.790.9% of flowCommon StockSEC:0000950170-24-136023:0
10,000 shares@ US$32.1313.9% of flowCommon StockSEC:0000950170-24-133434:0
15,481 shares@ US$32.2675.9% of flowCommon StockSEC:0000950170-24-121102:2
292 shares@ US$32.9370.1% of flowCommon StockSEC:0000950170-24-121102:3
40,716 shares@ US$21.0910.1% of flowCommon StockSEC:0000950170-24-121102:0
34,943 shares@ US$31.25412.8% of flowCommon StockSEC:0000950170-24-121102:1
25 of 55 declarations
About Young Jonathan
Young Jonathan is Chief Operating Officer at Akero Therapeutics, Inc. His 55 filings relate, in the recent sampled filings covering the period from 2021-05-04 to 2025-12-09, to sales totaling EUR 5149702, with the modal transaction nature listed as sell.
